Ep. 89 - "What's New" in cancer news and research: January, Cervical Cancer Awareness

January is Cervical Cancer Awareness Month, and today’s episode is about what we can do now and what’s finally changing for the better.In this conversation, we break down:What cervical cancer is and how it developsWhy screening and HPV vaccination save livesCommon myths that still prevent people from getting protectedAnd a practice-changing clinical trial that’s redefining treatment for people with high-risk cervical cancerWe also dive into newly released data from a major international phase 3 trial showing that adding immunotherapy to standard chemoradiation helps people with high-risk, locally advanced cervical cancer live longer and lowers the risk of recurrence—a breakthrough that’s been decades in the making.This episode is about access, prevention, informed choice, and real hope, without fear-based messaging or medical jargon.🎗️ Cervical Cancer BasicsHow cervical cancer formsWho is at higher riskWhy early detection makes such a differenceLearn more:Cleveland Clinic – Cervical Cancer Overviewhttps://my.clevelandclinic.org/health/diseases/12216-cervical-cancer🩺 Screening Guidelines: What You Actually Need to KnowUpdated cervical cancer screening recommendationsPap tests vs HPV testingWhy screening intervals have changed—and why that’s a good thingSource:American College of Obstetricians and Gynecologists (ACOG)Updated Cervical Cancer Screening Guidelineshttps://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines💉 HPV Vaccine: Separating Facts from FearWhat HPV is and how it relates to cervical cancerWhy the HPV vaccine is about cancer prevention, not behaviorAddressing common myths with science, not shameSources:Society of Behavioral Medicine – 7 HPV Vaccine Mythshttps://www.sbm.org/healthy-living/7-hpv-vaccine-mythsCDC – HPV Vaccine Safetyhttps://www.cdc.gov/vaccine-safety/vaccines/hpv.html🔬 New Research That’s Changing TreatmentWe break down results from a major phase 3 international study (KEYNOTE-A18 / ENGOT-cx11 / GOG-3047) that found:Adding pembrolizumab (Keytruda) to standard chemoradiationImproved overall survival and progression-free survivalFor people with high-risk, locally advanced cervical cancerWith a manageable and well-understood safety profileThis research is now being recognized as practice-changing and is expected to redefine the standard of care.💙 Why This MattersCervical cancer is one of the most preventable cancers, yet people still fall through the cracks due to:MisinformationBarriers to screeningLimited access to careThis episode centers education, compassion, and autonomy—because knowledge should empower, not scare.📚 Additional ResourcesAmerican Association for Cancer Research – Cervical Cancer Awareness Monthhttps://www.aacr.org/patients-caregivers/awareness-months/cervical-cancer-awareness-month/